These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 14520463)

  • 1. Wnt-signalling pathway in ovarian epithelial tumours: increased expression of beta-catenin and GSK3beta.
    Rask K; Nilsson A; Brännström M; Carlsson P; Hellberg P; Janson PO; Hedin L; Sundfeldt K
    Br J Cancer; 2003 Oct; 89(7):1298-304. PubMed ID: 14520463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenomatous polyposis coli (APC) protein expression in primary and metastatic serous ovarian carcinoma.
    Karbova E; Davidson B; Metodiev K; Tropé CG; Nesland JM
    Int J Surg Pathol; 2002 Jul; 10(3):175-80. PubMed ID: 12232570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A second protein kinase CK1-mediated step negatively regulates Wnt signalling by disrupting the lymphocyte enhancer factor-1/beta-catenin complex.
    Hämmerlein A; Weiske J; Huber O
    Cell Mol Life Sci; 2005 Mar; 62(5):606-18. PubMed ID: 15747065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morphological and transcriptional responses of untransformed intestinal epithelial cells to an oncogenic beta-catenin protein.
    Naishiro Y; Yamada T; Idogawa M; Honda K; Takada M; Kondo T; Imai K; Hirohashi S
    Oncogene; 2005 Apr; 24(19):3141-53. PubMed ID: 15735679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphoid enhancer factor-1 blocks adenomatous polyposis coli-mediated nuclear export and degradation of beta-catenin. Regulation by histone deacetylase 1.
    Henderson BR; Galea M; Schuechner S; Leung L
    J Biol Chem; 2002 Jul; 277(27):24258-64. PubMed ID: 11986304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of ovarian mucinous carcinoma and metastatic colorectal adenocarcinoma by immunostaining with beta-catenin.
    Chou YY; Jeng YM; Kao HL; Chen T; Mao TL; Lin MC
    Histopathology; 2003 Aug; 43(2):151-6. PubMed ID: 12877730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Restoration of full-length adenomatous polyposis coli (APC) protein in a colon cancer cell line enhances cell adhesion.
    Faux MC; Ross JL; Meeker C; Johns T; Ji H; Simpson RJ; Layton MJ; Burgess AW
    J Cell Sci; 2004 Jan; 117(Pt 3):427-39. PubMed ID: 14679305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Wnt-independent beta-catenin transactivation in tumor development.
    Lu Z; Hunter T
    Cell Cycle; 2004 May; 3(5):571-3. PubMed ID: 15107603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear endpoint of Wnt signaling: neoplastic transformation induced by transactivating lymphoid-enhancing factor 1.
    Aoki M; Hecht A; Kruse U; Kemler R; Vogt PK
    Proc Natl Acad Sci U S A; 1999 Jan; 96(1):139-44. PubMed ID: 9874785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E-cadherin binding prevents beta-catenin nuclear localization and beta-catenin/LEF-1-mediated transactivation.
    Orsulic S; Huber O; Aberle H; Arnold S; Kemler R
    J Cell Sci; 1999 Apr; 112 ( Pt 8)():1237-45. PubMed ID: 10085258
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ubiquitin-proteasome pathway and serine kinase activity modulate adenomatous polyposis coli protein-mediated regulation of beta-catenin-lymphocyte enhancer-binding factor signaling.
    Easwaran V; Song V; Polakis P; Byers S
    J Biol Chem; 1999 Jun; 274(23):16641-5. PubMed ID: 10347231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of S33/S37 phosphorylated beta-catenin in normal and transformed cells.
    Sadot E; Conacci-Sorrell M; Zhurinsky J; Shnizer D; Lando Z; Zharhary D; Kam Z; Ben-Ze'ev A; Geiger B
    J Cell Sci; 2002 Jul; 115(Pt 13):2771-80. PubMed ID: 12077367
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression and significance of p-AKT, p-GSK3β and β-catenin in epithelial carcinoma of ovary].
    Wei X; Lü QJ; Sun HX; Qi YF; Wang JO; Cao CC
    Zhonghua Bing Li Xue Za Zhi; 2012 Feb; 41(2):86-90. PubMed ID: 22455883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the {beta}-catenin/T-cell-specific transcription factor/lymphoid enhancer factor-1 pathway by plasminogen activators in ECV304 carcinoma cells.
    Maupas-Schwalm F; Robinet C; Augé N; Thiers JC; Garcia V; Cambus JP; Salvayre R; Nègre-Salvayre A
    Cancer Res; 2005 Jan; 65(2):526-32. PubMed ID: 15695395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peroxisome proliferator-activated receptor gamma activation can regulate beta-catenin levels via a proteasome-mediated and adenomatous polyposis coli-independent pathway.
    Sharma C; Pradeep A; Wong L; Rana A; Rana B
    J Biol Chem; 2004 Aug; 279(34):35583-94. PubMed ID: 15190077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological relevance of E-cadherin-catenin complex proteins in primary epithelial ovarian tumours.
    Faleiro-Rodrigues C; Macedo-Pinto IM; Maia SS; Vieira RH; Lopes CS
    Gynecol Obstet Invest; 2005; 60(2):75-83. PubMed ID: 15785075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta- and gamma-catenin mutations, but not E-cadherin inactivation, underlie T-cell factor/lymphoid enhancer factor transcriptional deregulation in gastric and pancreatic cancer.
    Caca K; Kolligs FT; Ji X; Hayes M; Qian J; Yahanda A; Rimm DL; Costa J; Fearon ER
    Cell Growth Differ; 1999 Jun; 10(6):369-76. PubMed ID: 10392898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormalities of the cadherin-catenin complex in chemically-induced colo-rectal carcinogenesis.
    Tucker E; Buda A; Janghra B; Cpoad J; Moorghan M; Havler M; Dettmar P; Pignatelli M
    Proc Nutr Soc; 2003 Feb; 62(1):229-36. PubMed ID: 12756972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bridging of beta-catenin and glycogen synthase kinase-3beta by axin and inhibition of beta-catenin-mediated transcription.
    Sakanaka C; Weiss JB; Williams LT
    Proc Natl Acad Sci U S A; 1998 Mar; 95(6):3020-3. PubMed ID: 9501208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of E-cadherin, alpha-catenin and beta-catenin in normal ovarian surface epithelium and epithelial ovarian cancers.
    Davies BR; Worsley SD; Ponder BA
    Histopathology; 1998 Jan; 32(1):69-80. PubMed ID: 9522220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.